REFERENCES:
1. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. The Lancet Oncology.2020;21(3):335-337.
2. Zhang L, Zhu F, Xie L, et al. Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan, China. Annals of oncology : official journal of the European Society for Medical Oncology. 2020.
3. Baxi SS, Pinheiro LC, Patil SM, Pfister DG, Oeffinger KC, Elkin EB. Causes of death in long-term survivors of head and neck cancer.Cancer. 2014;120(10):1507-1513.
4. Ferrier MB, Spuesens EB, Le Cessie S, Baatenburg de Jong RJ. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Archives of otolaryngology–head & neck surgery. 2005;131(1):27-32.
5. Francis DO, Weymuller EA, Jr., Parvathaneni U, Merati AL, Yueh B. Dysphagia, stricture, and pneumonia in head and neck cancer patients: does treatment modality matter? The Annals of otology, rhinology, and laryngology. 2010;119(6):391-397.
6. Kawakita D, Abdelaziz S, Chen Y, et al. Adverse respiratory outcomes among head and neck cancer survivors in the Utah Cancer Survivors Study.Cancer. 2020;126(4):879-885.
7. Rose BS, Jeong JH, Nath SK, Lu SM, Mell LK. Population-based study of competing mortality in head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011;29(26):3503-3509.
8. Shen W, Sakamoto N, Yang L. Cancer-specific mortality and competing mortality in patients with head and neck squamous cell carcinoma: a competing risk analysis. Annals of surgical oncology.2015;22(1):264-271.
9. Sucharew H, Macaluso M. Progress Notes: Methods for Research Evidence Synthesis: The Scoping Review Approach. Journal of hospital medicine. 2019;14(7):416-418.
10. Couch RB, Englund JA, Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. The American journal of medicine. 1997;102(3a):2-9; discussion 25-26.
11. Rolston KV. The spectrum of pulmonary infections in cancer patients.Current opinion in oncology. 2001;13(4):218-223.
12. Stover DE, Kaner RJ. Pulmonary complications in cancer patients.CA: a cancer journal for clinicians. 1996;46(5):303-320.
13. Kamboj M, Sepkowitz KA. Nosocomial infections in patients with cancer. The Lancet Oncology. 2009;10(6):589-597.
14. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia.Lancet (London, England). 2011;377(9773):1264-1275.
15. Ueda M, Martins R, Hendrie PC, et al. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal.Journal of the National Comprehensive Cancer Network : JNCCN.2020:1-4.
16. Livingston E, Bucher K. Coronavirus Disease 2019 (COVID-19) in Italy. Jama. 2020.
17. Onder G, Rezza G, Brusaferro S. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.Jama. 2020.
18. WHO. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Accessed April 12, 2020.
19. Wang H, Zhang L. Risk of COVID-19 for patients with cancer.The Lancet Oncology. 2020.
20. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England).2020;395(10223):507-513.
21. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. Jama. 2020.
22. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet (London, England).2020;395(10229):1054-1062.
23. Lei S JF, Su W, et al. Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection. EClinicalMedicine. 2020. https://doi.org/10.1016/j.eclinm.2020.100331.
24. Semenov YR, Starmer HM, Gourin CG. The effect of pneumonia on short-term outcomes and cost of care after head and neck cancer surgery.The Laryngoscope. 2012;122(9):1994-2004.
25. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):394-424.
26. Argiris A, Brockstein BE, Haraf DJ, et al. Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004;10(6):1956-1962.
27. Mell LK, Dignam JJ, Salama JK, et al. Predictors of competing mortality in advanced head and neck cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010;28(1):15-20.
28. Montero-Miranda PH, Ganly I. Survivorship–competing mortalities, morbidities, and second malignancies. Otolaryngologic clinics of North America. 2013;46(4):681-710.
29. Piccirillo JF, Vlahiotis A. Comorbidity in patients with cancer of the head and neck: prevalence and impact on treatment and prognosis.Current oncology reports. 2006;8(2):123-129.
30. Landis SH, El-Hariry IA, van Herk-Sukel MP, et al. Prevalence and incidence of acute and chronic comorbidity in patients with squamous cell carcinoma of the head and neck. Head & neck.2012;34(2):238-244.
31. Piccirillo JF. Importance of comorbidity in head and neck cancer.The Laryngoscope. 2015;125(10):2242.
32. Ostroff JS, Jacobsen PB, Moadel AB, et al. Prevalence and predictors of continued tobacco use after treatment of patients with head and neck cancer. Cancer. 1995;75(2):569-576.
33. Smith J, Nastasi D, Tso R, Vangaveti V, Renison B, Chilkuri M. The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2019;135:51-57.
34. Browman GP, Wong G, Hodson I, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. The New England journal of medicine. 1993;328(3):159-163.
35. van Imhoff LC, Kranenburg GG, Macco S, et al. Prognostic value of continued smoking on survival and recurrence rates in patients with head and neck cancer: A systematic review. Head & neck. 2016;38 Suppl 1:E2214-2220.
36. Hashibe M, Brennan P, Chuang SC, et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2009;18(2):541-550.
37. Giraldi L, Leoncini E, Pastorino R, et al. Alcohol and cigarette consumption predict mortality in patients with head and neck cancer: a pooled analysis within the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Annals of oncology : official journal of the European Society for Medical Oncology.2017;28(11):2843-2851.
38. Spitz MR, Fueger JJ, Chamberlain RM, Goepfert H, Newell GR. Cigarette smoking patterns in patients after treatment of upper aerodigestive tract cancers. Journal of cancer education : the official journal of the American Association for Cancer Education.1990;5(2):109-113.
39. Bhattacharyya N, Fried MP. Benchmarks for mortality, morbidity, and length of stay for head and neck surgical procedures. Archives of otolaryngology–head & neck surgery. 2001;127(2):127-132.
40. Buitelaar DR, Balm AJ, Antonini N, van Tinteren H, Huitink JM. Cardiovascular and respiratory complications after major head and neck surgery. Head & neck. 2006;28(7):595-602.
41. Manikantan K, Khode S, Sayed SI, et al. Dysphagia in head and neck cancer. Cancer treatment reviews. 2009;35(8):724-732.
42. Mets OM, Buckens CF, Zanen P, et al. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans. Jama. 2011;306(16):1775-1781.
43. Ohashi Y, Nakai Y, Ikeoka H, et al. Functional and morphological pathology of the nasal mucosa after x-ray irradiation. Clin Otolaryngol Allied Sci. 1988;13(6):435-446.
44. Lou PJ, Chen WP, Tai CC. Delayed irradiation effects on nasal epithelium in patients with nasopharyngeal carcinoma. An ultrastructural study. The Annals of otology, rhinology, and laryngology.1999;108(5):474-480.
45. Ohyama MM, Y.; Yamamoto, S.; Fujita, T.; Taniguchi, T. Surface ultrastructure of pathological mucosa of the human larynx.Otologica Fukuoka. 1977;23:646-659.
46. Stringer SP, Stiles W, Slattery WH, 3rd, et al. Nasal mucociliary clearance after radiation therapy. The Laryngoscope. 1995;105(4 Pt 1):380-382.
47. Surico G, Muggeo P, Mappa L, et al. Impairment of nasal mucociliary clearance after radiotherapy for childhood head cancer. Head & neck. 2001;23(6):461-466.
48. Alon EE, Lipschitz N, Bedrin L, et al. Delayed Sino-nasal Complications of Radiotherapy for Nasopharyngeal Carcinoma.Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.2014;151(2):354-358.
49. Brown LR, Dreizen S, Handler S, Johnston DA. Effect of radiation-induced xerostomia on human oral microflora. Journal of dental research. 1975;54(4):740-750.
50. Himi T, Kukuminato Y, Kita H, Yoshioka I, Kataura A. Effect of radiotherapy on the levels of secretory immunoglobulin A against indigenous and virulent streptococci. Otolaryngology–head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery. 1997;117(5):433-437.
51. Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol.2004;31(6):726-733.
52. Dye JA, Adler KB. Effects of cigarette smoke on epithelial cells of the respiratory tract. Thorax. 1994;49(8):825-834.
53. Arcavi L, Benowitz NL. Cigarette smoking and infection.Archives of internal medicine. 2004;164(20):2206-2216.
54. Hussain M, Kish JA, Crane L, et al. The role of infection in the morbidity and mortality of patients with head and neck cancer undergoing multimodality therapy. Cancer. 1991;67(3):716-721.
55. Mirabile A, Vismara C, Crippa F, et al. Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy. Head & neck. 2016;38 Suppl 1:E1009-1013.
56. Merlano MC, Monteverde M, Colantonio I, et al. Impact of age on acute toxicity induced by bio- or chemo-radiotherapy in patients with head and neck cancer. Oral oncology. 2012;48(10):1051-1057.
57. Winther B. Rhinovirus infections in the upper airway.Proceedings of the American Thoracic Society. 2011;8(1):79-89.
58. Dandachi D, Rodriguez-Barradas MC. Viral pneumonia: etiologies and treatment. Journal of investigative medicine : the official publication of the American Federation for Clinical Research.2018;66(6):957-965.
59. Seki M, Kosai K, Yanagihara K, et al. Disease severity in patients with simultaneous influenza and bacterial pneumonia. Internal medicine (Tokyo, Japan). 2007;46(13):953-958.
60. Klein EY, Monteforte B, Gupta A, et al. The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.Influenza and other respiratory viruses. 2016;10(5):394-403.
61. Sepehr A, Santos BJ, Chou C, et al. Antibiotics in head and neck surgery in the setting of malnutrition, tracheotomy, and diabetes.The Laryngoscope. 2009;119(3):549-553.
62. Panghal M, Kaushal V, Kadayan S, Yadav JP. Incidence and risk factors for infection in oral cancer patients undergoing different treatments protocols. BMC oral health. 2012;12:22.
63. Bartlett JG. Anaerobic bacterial infection of the lung.Anaerobe. 2012;18(2):235-239.
64. Langerman A, Maccracken E, Kasza K, Haraf DJ, Vokes EE, Stenson KM. Aspiration in chemoradiated patients with head and neck cancer.Archives of otolaryngology–head & neck surgery.2007;133(12):1289-1295.
65. Shirasu H, Yokota T, Hamauchi S, et al. Risk factors for aspiration pneumonia during concurrent chemoradiotherapy or bio-radiotherapy for head and neck cancer. BMC cancer. 2020;20(1):182.
66. Kawai S, Yokota T, Onozawa Y, et al. Risk factors for aspiration pneumonia after definitive chemoradiotherapy or bio-radiotherapy for locally advanced head and neck cancer: a monocentric case control study.BMC cancer. 2017;17(1):59.
67. Chu CN, Muo CH, Chen SW, Lyu SY, Morisky DE. Incidence of pneumonia and risk factors among patients with head and neck cancer undergoing radiotherapy. BMC cancer. 2013;13:370.
68. Hunter KU, Lee OE, Lyden TH, et al. Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors. Head & neck.2014;36(1):120-125.
69. Mortensen HR, Jensen K, Grau C. Aspiration pneumonia in patients treated with radiotherapy for head and neck cancer. Acta oncologica (Stockholm, Sweden). 2013;52(2):270-276.
70. Nguyen NP, Frank C, Moltz CC, et al. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2006;80(3):302-306.
71. Chen SW, Yang SN, Liang JA, Lin FJ. The outcome and prognostic factors in patients with aspiration pneumonia during concurrent chemoradiotherapy for head and neck cancer. European journal of cancer care. 2010;19(5):631-635.
72. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2002;53(1):23-28.
73. Komiya K, Ishii H, Umeki K, et al. Impact of aspiration pneumonia in patients with community-acquired pneumonia and healthcare-associated pneumonia: a multicenter retrospective cohort study. Respirology (Carlton, Vic). 2013;18(3):514-521.
74. Lanspa MJ, Jones BE, Brown SM, Dean NC. Mortality, morbidity, and disease severity of patients with aspiration pneumonia. Journal of hospital medicine. 2013;8(2):83-90.
75. Xu B, Boero IJ, Hwang L, et al. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer.2015;121(8):1303-1311.
76. Chang CC, Lee WT, Hsiao JR, et al. Oral hygiene and the overall survival of head and neck cancer patients. Cancer medicine.2019;8(4):1854-1864.
77. Farquhar DR, Divaris K, Mazul AL, Weissler MC, Zevallos JP, Olshan AF. Poor oral health affects survival in head and neck cancer.Oral oncology. 2017;73:111-117.
78. Friemel J, Foraita R, Gunther K, et al. Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients. BMC oral health. 2016;16:33.
79. Hashim D, Sartori S, Brennan P, et al. The role of oral hygiene in head and neck cancer: results from International Head and Neck Cancer Epidemiology (INHANCE) consortium. Annals of oncology : official journal of the European Society for Medical Oncology.2016;27(8):1619-1625.
80. Zeng XT, Leng WD, Zhang C, Liu J, Cao SY, Huang W. Meta-analysis on the association between toothbrushing and head and neck cancer.Oral oncology. 2015;51(5):446-451.
81. Sjogren P, Nilsson E, Forsell M, Johansson O, Hoogstraate J. A systematic review of the preventive effect of oral hygiene on pneumonia and respiratory tract infection in elderly people in hospitals and nursing homes: effect estimates and methodological quality of randomized controlled trials. Journal of the American Geriatrics Society.2008;56(11):2124-2130.
82. Sjogren P, Wardh I, Zimmerman M, Almstahl A, Wikstrom M. Oral Care and Mortality in Older Adults with Pneumonia in Hospitals or Nursing Homes: Systematic Review and Meta-Analysis. Journal of the American Geriatrics Society. 2016;64(10):2109-2115.
83. Muller F. Oral hygiene reduces the mortality from aspiration pneumonia in frail elders. Journal of dental research. 2015;94(3 Suppl):14s-16s.
84. Yokota T, Tachibana H, Konishi T, et al. Multicenter phase II study of an oral care program for patients with head and neck cancer receiving chemoradiotherapy. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.2016;24(7):3029-3036.